448933289
18 Nov 2019
Switzerland CHMP recommends EU approval of Roches Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment, Switzerland
Severity: Notice
Message: Undefined variable: region
Filename: views/login_detail_view_new_V1.php
Line Number: 393
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.